Comments

Rani Therapeutics Hldgs Stock Price, Quotes and Forecasts

Q: What sector and industry does Rani Therapeutics Hldgs (RANI) operate in?

Rani Therapeutics Hldgs is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

RANINASDAQ

Logo brought to you by Benzinga Data

Trade with Public

$1.93

-0.34-15.01%

Last update: 1:40 PM

Q3 2025 Earnings were released on Thu Nov 6th, before the market open

Rani Therapeutics Hldgs (RANI) Forecast

News Earnings Options Analyst Ratings Insider Trades Short Interest Stock Report

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Rani Therapeutics Hldgs Stock Price, Quotes and Forecasts | NASDAQ:RANI | Benzinga

Explore Rani Therapeutics Hldgs stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for RANI.

Open	$1.95
Close	-
Volume / Avg.	5.22M / 16.50M
Day Range	$1.83 - $2.07
52 Wk Range	0.39 - 3.87
Market Cap	$188.18M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	56
Short Interest	0.13%
Days to Cover	1

Recent News

4 Biotech Stocks Lifting Off As Momentum Builds

Biotech stocks have trailed the broader market this year, but more names are starting to show strength as the rally expands and major indexes reach record levels.

Dylan Berman

Why Delcath Systems Shares Are Trading Higher By Over 14%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Gold Falls 1%; SLB Posts Better-Than-Expected Q3 Earnings

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

May

Oct

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.1

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$1.95
Close	-
Volume / Avg.	5.22M / 16.50M
Day Range	$1.83 - $2.07
52 Wk Range	0.39 - 3.87
Market Cap	$188.18M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	56
Short Interest	0.13%
Days to Cover	1

About Rani Therapeutics Holdings Inc

Sector

Health Care

Industry

Pharmaceuticals

Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Rani Therapeutics Hldgs (RANI) stock?

You can purchase shares of Rani Therapeutics Hldgs (NASDAQ:RANI) through any online brokerage.

View our list of the best stock brokerages

Who are Rani Therapeutics Hldgs (RANI) competitors?

Other companies in Rani Therapeutics Hldgs’s space includes: Atea Pharmaceuticals (NASDAQ:AVIR), MediWound (NASDAQ:MDWD), Bioage Labs (NASDAQ:BIOA), Aardvark Therapeutics (NASDAQ:AARD) and Incannex Healthcare (NASDAQ:IXHL).

What is the forecast, or price target, for Rani Therapeutics Hldgs (RANI) stock?

Rani Therapeutics Hldgs has a consensus price target of $10.55.

What is the current price for Rani Therapeutics Hldgs (RANI)?

The stock price for Rani Therapeutics Hldgs (NASDAQ: RANI) is $1.9292 last updated November 7, 2025 at 1:40 PM EST.

Does Rani Therapeutics Hldgs (RANI) pay a dividend?

There are no upcoming dividends for Rani Therapeutics Hldgs.

When is Rani Therapeutics Hldgs (NASDAQ:RANI) reporting earnings?

Rani Therapeutics Hldgs’s Q3 earnings are confirmed for Thursday, November 6, 2025.

Is Rani Therapeutics Hldgs (RANI) going to split?

There is no upcoming split for Rani Therapeutics Hldgs.

What sector and industry does Rani Therapeutics Hldgs (RANI) operate in?

Rani Therapeutics Hldgs is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.